Edward Kaye - Crunchbase Person Profile

Start Free Trial

Pricing

Overview

Number of Portfolio Companies

Number of Exits

Unlock for free

Location Boston, Massachusetts, United States
Regions Greater Boston Area, East Coast, New England
Gender Male

Investor Type
obfuscated
obfuscation
Number of Exits
obfuscated
obfuscation

Facebook View on Facebook
LinkedIn View on LinkedIn

Edward M. Kaye is based out of Boston, Massachusetts, and is the CEO and Director of Aurora Therapeutics. Edward previously worked at Stoke Therapeutics as a chief executive officer and director. Edward M. Kaye attended Loyola University Chicago.

Personal Investments

Number of Investments

Edward Kaye

invested in

Xinvento

obfuscation

Announced Date	Organization Name	Lead Investor	Funding Round	Money Raised
obfuscated obfuscation	Xinvento	—	Seed Round - Xinvento	obfuscated obfuscation

Exits

Number of Exits

Unlock for free

Edward Kaye

has

obfuscation

exit -

Xinvento

Edward Kaye

has

obfuscation

exits. Their most notable exits are

Xinvento

Xinvento Xinvento provides a credible alternative treatment for congenital hyperinsulinism.

Jobs

Number of Current Jobs

Number of Past Jobs

Edward Kaye

has

current jobs as

CEO and Director

Aurora Therapeutics

and

Director

Avidity Biosciences

. Additionally,

Edward Kaye

has had

past jobs including

CEO & Founder

Stoke Therapeutics

Aurora Therapeutics CEO and DirectorSep 2025
Avidity Biosciences DirectorJun 2019

Organization Name	Title At Company	Start Date	End Date
Stoke Therapeutics	CEO & Founder	Oct 2017	Mar 2025
Sarepta Therapeutics	President & CEO	—	—

Board and Advisor Roles

Number of Current Board & Advisor Roles

Edward Kaye

is the

Scientific Advisory Board

Lumos Pharma

Lumos Pharma Scientific Advisory Board

Education

Edward Kaye

studied at

Loyola University Chicago

and

Loyola University Chicago

Loyola University Chicago BSBiology & Chemistry19671971
Loyola University Chicago MDPediatrics, Neurology, Biochemical Genetics

Events

Number of Events

Edward Kaye

has participated in

events. They most recently attended, or will attend,

FierceBiotech 2nd Drug Development Forum

Sep 25, 2017

FierceBiotech 2nd Drug Development Forum Speaker Boston, Massachusetts, United States, North AmericaSep 25, 2017
TIDES: Oligonucleotide and Peptide Therapeutics 2017 Speaker San Diego, California, United States, North AmericaApr 30, 2017

Recent News and Activity

Number of News Articles

Funding Round•

Apr 21, 2022

Xinvento raised

obfuscation

from Daniel A. de Boer and 7 other investors

Discover more funding rounds

News•

Nov 16, 2016